BioLineRx In-Licenses Anti-Inflammatory Peptide
Exclusive, worldwide rights obtained from two Israeli technology firms covers development and commercialization. BioLineRx obtained a novel peptide for the treatment of inflammatory diseases from Yissum Resear…
Read guide →